Myocardial Oxygen Consumption in Patients with Idiopathic Dilated Cardiomyopathy: Effects of Vasodilating and Inotropic Agents
Idiopathic dilated cardiomyopathy is a myocardial disease of unknown origin. Several causal factors are discussed. One hypothesis involves energy depriviation in the failing myocardium, and a number of arguments exist for such an energy-starving situation [22, 23]. These include the following: (a) In some studies investigating the energy state of hypertrophied and failing myocardium, a reduced content of high energy phosphates was reported [5, 39]. However, these findings were not confirmed by others [33, 34]. (b) In the failing human myocardium, a reduction in myofibrillar ATPase activity [1, 25, 30] and a shift of the isoenzyme pattern of lactate dehydrogenase  has been observed. Both changes may be interpreted in terms of adaptation to energy depletion; reduced myofibrillar ATPase activity is associated with more economical tension development, as shown in mammalian myocardium [2, 15, 16] and in human myocardium , and the shifts in the isoforms of the lactate dehydrogenase are indicators of anaerobic glycolysis . (c) A reduction in capillary density may lead to increased diffusion distances . (d) A reduced ratio of mitochondria and myofibrillar volumes indicates a mismatch between the number of ATP synthesizing sites and the number of ATP consuming sites [4, 31]. (e) Reduced coronary reserve has been observed in patients with dilated cardiomyopathy using the dipyridamole test [28, 29, 32].
KeywordsDilate Cardiomyopathy Myocardial Blood Flow Myocardial Oxygen Consumption Idiopathic Dilate Cardiomyopathy Additional Energy Consumption
Unable to display preview. Download preview PDF.
- 2.Alpert NR, Mulieri LA (1982) Increasing myothermal economy of isometric force genera- tion in compensated cardiac hypertrophy induced by pulmonary artery constriction in rabbit. A characterization of heat liberation in normal and hypertrophied papillary muscle. Circ Res 50:491–500PubMedGoogle Scholar
- 9.Dies F, Krell MJ, Whitlow P, Liang C-S, Goldenberg I, Applefeld MM, Gilbert EM (1986) Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 74 [Suppl II]:152Google Scholar
- 12.Hasenfuss G, Holubarsch C, Heiss HW, Bonzel T, Funfack M, Revenaugh M, Meinertz T, Just H (1987) Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilated cardiomyopathy. Clin Cardiol 10:223–327Google Scholar
- 15.Holubarsch C, Goulette RP, Mulieri LA, Alpert NR (1983) Heat liberation in experimentally induced tetanic contractions of myocardium from normal and Goldblatt rats. In: Jacob R (ed) Cardiac adaptation of hemodynamic overload, training and stress. Steinkopff, Darmstadt, pp 158–166Google Scholar
- 19.Holubarsch C, Hasenfuss G, Blanchard E, Mulieri LA, Alpert NR (1989) Influence of the phosphodiesterase inhibitor E-1020 on mechanics and energetics in guinea pig papillary muscles. Circulation 80 [Suppl II]:612Google Scholar
- 21.Holubarsch Ch, Hasenfuss G, Thiefelder L, Just H (1991) Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure. Bas Res Cardiol 86, Suppl I:107–112Google Scholar
- 22.Katz AM (1986) Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation 73 [Suppl III]: 184–188Google Scholar
- 27.Mirsky I (1979) Elastic properties of the myocardium: a quantitative approach with physiological and clinical applications. In: Berne RM (ed) Handbook of physiology. The cardiovascular system. American Physiological Society, Washington, pp 497–531Google Scholar
- 30.Pagani ED, Alousi AA, Grant AM, Order TM, Dziuban SW, Allen PD (1988) Changes in myofibrillar content and Mg-ATPase activity in ventricular tissue from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ Res 63:380–385PubMedGoogle Scholar
- 33.Regitz V, Rappolder M, Bossaller C, Strasser R, Fleck E (1990) Myocardial ATP, ADP and AMP in heart failure of different origins. Eur Heart J 11[Suppl]:189Google Scholar
- 37.SOLVD investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection farctions and congestive heart failure. N Engl J Med 325:293–302Google Scholar
- 42.Viquerat CE, Kereiakes D, Morris L, Daly PA, Wexman M, Frank P, Parmley WW, Chatterjee K (1985) Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure. J Am Coll Cardiol 5:326–332PubMedCrossRefGoogle Scholar